Geoff Oxnard: I’m joining BlossomHill Therapeutics as CMO!
Geoff Oxnard, Thoracic Oncologist at Boston Medical Center, shared a post on X:
“Excited to announce I’m joining BlossomHill Therapeutics as CMO!
I’ve always believed in patient-centered cancer therapies. None better to team with than our CEO Jean Cui who designed some of the most effective and creative macrocyclic TKIs on the market.”
Geoff Oxnard is the Chief Medical Officer at BlossomHill Therapeutics, Inc., and a Thoracic Oncologist at Boston Medical Center. A clinical investigator and translational scientist, Dr. Oxnard’s work has contributed to identifying key genetic alterations in cancer and translating these findings into clinical trials. He focuses on developing innovative diagnostic tools and treatment strategies to improve the precision and effectiveness of cancer therapies.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023